P578: GILTERITINIB FOR RELAPSED/REFRACTORY FLT3 MUTATED ACUTE MYELOID LEUKEMIA A REAL-WORLD, MULTI-CENTER, MATCHED ANALYSIS

• S. Shimony,
• J. Canaani,
• E. Kugler,
• B. Nachmias,
• R. Ram,
• A. Frisch,
• C. Ganzel,
• V. Vainstein,
• Y. Moshe,
• S. Aumann,
• M. Yeshurun,
• Y. Ofran,
• P. Raanani,
• O. Wolach

Affiliations

S. Shimony

1 Leukemia, Dana Farber Cancer Institute, Boston, United States of America

J. Canaani

3 Sackler Medical School, Tel Aviv University, Tel Aviv

E. Kugler

2 hematology, Rabin medical center, Petah Tikva

B. Nachmias

5 hematology, Hadassah Medical Center and Hebrew university Faculty, Jerusalem

R. Ram

6 BMT Unit

A. Frisch

8 Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, and Rappaport Faculty of Medicine - Technion, Haifa

C. Ganzel

9 hematology, Shaare Zedek Medical Center, and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem

V. Vainstein

5 hematology, Hadassah Medical Center and Hebrew university Faculty, Jerusalem

Y. Moshe

3 Sackler Medical School, Tel Aviv University, Tel Aviv

S. Aumann

5 hematology, Hadassah Medical Center and Hebrew university Faculty, Jerusalem

M. Yeshurun

2 hematology, Rabin medical center, Petah Tikva

Y. Ofran

9 hematology, Shaare Zedek Medical Center, and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem

P. Raanani

2 hematology, Rabin medical center, Petah Tikva

O. Wolach

2 hematology, Rabin medical center, Petah Tikva